BlackRock Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $261K | Sell |
44,545
-1,108
| -2% | -$6.49K | ﹤0.01% | 2511 |
|
|
2016
Q3 | $242K | Buy |
45,653
+2,413
| +6% | +$12.8K | ﹤0.01% | 2524 |
|
|
2016
Q2 | $286K | Sell |
43,240
-4,602
| -10% | -$30.4K | ﹤0.01% | 2390 |
|
|
2016
Q1 | $223K | Buy |
47,842
+3,108
| +7% | +$14.5K | ﹤0.01% | 2456 |
|
|
2015
Q4 | $226K | Sell |
44,734
-21,002
| -32% | -$106K | ﹤0.01% | 2473 |
|
|
2015
Q3 | $231K | Sell |
65,736
-17,061
| -21% | -$60K | ﹤0.01% | 2602 |
|
|
2015
Q2 | $826K | Buy |
82,797
+19,920
| +32% | +$199K | ﹤0.01% | 1770 |
|
|
2015
Q1 | $800K | Buy |
62,877
+13,180
| +27% | +$168K | ﹤0.01% | 1678 |
|
|
2014
Q4 | $703K | Sell |
49,697
-2,374
| -5% | -$33.6K | ﹤0.01% | 1707 |
|
|
2014
Q3 | $716K | Sell |
52,071
-10,361
| -17% | -$142K | ﹤0.01% | 1654 |
|
|
2014
Q2 | $960K | Sell |
62,432
-48,297
| -44% | -$743K | ﹤0.01% | 1492 |
|
|
2014
Q1 | $1.89M | Buy |
110,729
+57,368
| +108% | +$978K | ﹤0.01% | 1181 |
|
|
2013
Q4 | $691K | Buy |
53,361
+3,284
| +7% | +$42.5K | ﹤0.01% | 1756 |
|
|
2013
Q3 | $505K | Sell |
50,077
-993,740
| -95% | -$10M | ﹤0.01% | 1889 |
|
|
2013
Q2 | $7.8M | Buy |
+1,043,817
| New | +$7.8M | 0.01% | 840 |
|